Cambridge-based biotechnology company developing innovative approaches to understand and treat disease by studying the role of mechanical forces in biology. The company focuses on mechanobiology, the study of how cells sense and respond to physical forces, and applies advanced technologies to uncover new insights into disease mechanisms and therapeutic opportunities. By combining biological research, engineering principles, and computational approaches, Mechanome Bio aims to discover novel drug targets and develop next-generation therapies for conditions where cellular mechanics play a critical role. The company operates at the intersection of biology, engineering, and medicine, contributing to the advancement of precision healthcare and therapeutic innovation.